We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LABD market cap is 77.08M. The company's latest EPS is USD -4.7464 and P/E is -1.29.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 918k | 14k | 1.71M | 5.18M | 5.97M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -91.4M | -85.56M | -16.59M | 40.77M | -59.88M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End October 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 82.7M | 50.85M | 222.42M | 87.97M | 91.53M |
| Total Liabilities | 19.14M | 3.59M | 32.45M | 26.05M | 13.69M |
| Total Equity | 63.56M | 47.27M | 189.98M | 61.92M | 77.84M |
| Market Cap | 77.08M |
| Price to Earnings Ratio | -1.29 |
| Price to Sales Ratio | 12.98 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 1 |
| Dividend Yield | - |
| Shares Outstanding | 12.62M |
| Average Volume (1 week) | 18.69M |
| Average Volume (1 Month) | 15.81M |
| 52 Week Change | 6.45% |
| 52 Week High | 16.05 |
| 52 Week Low | 4.78 |
| Spread (Intraday) | 0.03 (0.49%) |
| Company Name | Direxion Daily S&P Biotech Bear 3X Shares |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
